Stem cell-based therapies are becoming increasingly common, especially in the treatment of blood cancers like lymphoma and leukemia. In these cases, the ...
Updated: 03/07/2019 11:00A
Teva Pharmaceutical Industries Ltd. and Celltrion Inc. announced on Tuesday they have received approval from the U.S. Food and Drug Administration for a biosimilar intended to treat several conditions of non-Hodgkins lymphoma, a certain type of blood ...
Updated: 11/29/2018 08:03A